Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 08:13 am Purchase |
2024-01-24 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 6,701,489 8.400% |
744,931 (+12.51%) |
Filing History |
| 2024-01-23 09:38 am Sale |
2023-12-31 | 13G | Avidity Biosciences, Inc. RNA |
STATE STREET CORP STT |
3,438,328 4.640% |
-131,799 (-3.69%) |
Filing History |
| 2023-12-04 4:13 pm Purchase |
2023-11-27 | 13G | Avidity Biosciences, Inc. RNA |
BRISTOL MYERS SQUIBB CO BMY |
5,075,304 6.400% |
5,075,304 (New Position) |
Filing History |
| 2023-07-10 10:20 am Purchase |
2023-07-07 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 10,622,863 14.999% |
5,697,486 (+115.68%) |
Filing History |
| 2023-02-14 1:36 pm Sale |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 0 0.000% |
-2,759,505 (Position Closed) |
Filing History |
| 2023-02-14 12:38 pm Purchase |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 6,707,287 10.100% |
1,627,761 (+32.05%) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Avidity Biosciences, Inc. RNA |
The Vanguard Group | 3,470,626 5.220% |
3,470,626 (New Position) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Avidity Biosciences, Inc. RNA |
FMR CORP | 4,925,377 7.412% |
1,148,853 (+30.42%) |
Filing History |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
BLACKROCK INC BLK |
5,286,174 8.000% |
1,988,694 (+60.31%) |
Filing History |
| 2023-02-03 2:15 pm Purchase |
2022-12-31 | 13G | Avidity Biosciences, Inc. RNA |
STATE STREET CORP STT |
3,570,127 5.370% |
3,570,127 (New Position) |
Filing History |
| 2023-02-02 4:15 pm Purchase |
2022-09-01 | 13D | Avidity Biosciences, Inc. RNA |
RTW Investments, LP | 5,956,558 9.000% |
1,961,558 (+49.10%) |
Filing History |
| 2023-01-11 11:50 am Purchase |
2022-12-30 | 13G | Avidity Biosciences, Inc. RNA |
Cowen Financial Products LLC | 5,188,366 6.450% |
1,924,216 (+58.95%) |
Filing History |
| 2022-12-30 4:30 pm Purchase |
2022-12-20 | 13G | Avidity Biosciences, Inc. RNA |
RA Capital Management, L.P. | 5,454,533 8.210% |
5,454,533 (New Position) |
Filing History |
| 2022-12-27 4:15 pm Purchase |
2022-12-14 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,762,115 5.070% |
750,000 (+37.27%) |
Filing History |
| 2022-08-18 3:38 pm Purchase |
2022-08-05 | 13G | Avidity Biosciences, Inc. RNA |
Cowen Financial Products LLC | 3,264,150 6.560% |
3,264,150 (New Position) |
Filing History |
| 2022-08-10 2:56 pm Sale |
2022-07-31 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 5,079,526 10.200% |
-2,652,320 (-34.30%) |
Filing History |
| 2022-02-14 3:06 pm Sale |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,012,115 4.290% |
-452,432 (-18.36%) |
Filing History |
| 2022-02-14 3:03 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
EcoR1 Capital LLC | 2,759,505 5.900% |
655,555 (+31.16%) |
Filing History |
| 2022-02-14 2:35 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
PRICE T ROWE ASSOCIATES INC | 7,731,846 16.400% |
1,916,636 (+32.96%) |
Filing History |
| 2022-02-14 1:12 pm Purchase |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
FEDERATED HERMES INC. FHI |
2,474,500 5.280% |
2,474,500 (New Position) |
Filing History |